374 related articles for article (PubMed ID: 28641097)
1. Long-term complications after hematopoietic cell transplantation.
Majhail NS
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):220-227. PubMed ID: 28641097
[TBL] [Abstract][Full Text] [Related]
2. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
Majhail NS; Rizzo JD
Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
[TBL] [Abstract][Full Text] [Related]
3. ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.
Hashmi SK; Lee SJ; Savani BN; Burns L; Wingard JR; Perales MA; Palmer J; Chow E; Meyer E; Marks D; Mohty M; Inamoto Y; Rodriguez C; Nagler A; Sauter C; Komanduri KV; Pidala J; Hamadani M; Johnston L; Shah N; Shaughnessy P; Hamilton BK; Majhail N; Kharfan-Dabaja MA; Schriber J; DeFilipp Z; Tarlock KG; Fanning S; Curtin P; Rizzo JD; Carpenter PA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1119-1124. PubMed ID: 29608957
[TBL] [Abstract][Full Text] [Related]
4. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
5. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
Saunders IM; Tan M; Koura D; Young R
Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
[TBL] [Abstract][Full Text] [Related]
6. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
[TBL] [Abstract][Full Text] [Related]
7. Managing Survivorship after Hematopoietic Cell Transplantation.
Khera N
Curr Hematol Malig Rep; 2023 Jun; 18(3):75-82. PubMed ID: 36995660
[TBL] [Abstract][Full Text] [Related]
8. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
[TBL] [Abstract][Full Text] [Related]
9. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
[TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
Hashmi SK; Bredeson C; Duarte RF; Farnia S; Ferrey S; Fitzhugh C; Flowers MED; Gajewski J; Gastineau D; Greenwald M; Jagasia M; Martin P; Rizzo JD; Schmit-Pokorny K; Majhail NS
Biol Blood Marrow Transplant; 2017 May; 23(5):717-725. PubMed ID: 27713091
[TBL] [Abstract][Full Text] [Related]
11. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
[TBL] [Abstract][Full Text] [Related]
12. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
[TBL] [Abstract][Full Text] [Related]
13. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
[TBL] [Abstract][Full Text] [Related]
14. [Long-term follow-up clinics after hematopoietic cell transplantation: its needs and challenges in Japan].
Kurosawa S
Rinsho Ketsueki; 2017; 58(10):2111-2123. PubMed ID: 28978856
[TBL] [Abstract][Full Text] [Related]
15. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.
Chow EJ; Cushing-Haugen KL; Cheng GS; Boeckh M; Khera N; Lee SJ; Leisenring WM; Martin PJ; Mueller BA; Schwartz SM; Baker KS
J Clin Oncol; 2017 Jan; 35(3):306-313. PubMed ID: 27870568
[TBL] [Abstract][Full Text] [Related]
17. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
18. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase.
Goldman JM; Majhail NS; Klein JP; Wang Z; Sobocinski KA; Arora M; Horowitz MM; Rizzo JD
J Clin Oncol; 2010 Apr; 28(11):1888-95. PubMed ID: 20212247
[TBL] [Abstract][Full Text] [Related]
19. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
20. Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
Tichelli A; Rovó A
Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
